Human growth hormone immunoglobulin fusion proteins
US8529899B2 · kind B2 · utility
2Cited by
0References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 11, 2012 |
| Grant date | Sep 10, 2013 |
| Priority date | — |
| Expiry date | Jun 11, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.